See this page online at: http://www.biotechfocus.com/2007Issue11
Sign up for your free subscription and keep up-to-date.
Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.
|
Clinical Development in Canada - the pros and cons
By Tonya Costoff and Shawn Lawrence
Deciding where to conduct a company’s clinical development is a massive decision that companies don’t take lightly. Companies need to consider such important factors as the cost involved, what the regulations are in that particular country, if there are enough people that would take part in the study and how hard/easy it would be to set up the logistics. |
|
More Than Just Pretty Colours: The Growing Impact Of Fluorescent Proteins In The Life Sciences
By Hui-wang Ai & Robert E. Campbell
How is it that a jellyfish sparked a revolution in biotechnology? |
|
Oncolytics Biotech working to uncover a Cancer Killer
By Shawn Lawrence
For decades scientists, researchers and even big pharma companies have all tried in vain to find the cure for cancer. While the concept of a magic bullet to beat the disease has long been abandoned, one company may have in fact uncovered a promising new treatment through the use of something that most people actually go out of their way to avoid: a virus. |
|
Research to Revenue outlines what it takes to build a successful company
Interview by Tonya Costoff
Promoting the growth of the biotechnology industry in Canada, The Biotechnology Initiative’s (TBI) ‘From Research to Revenue III’ closed out another successful National Biotechnology Week, building on the progress made by its first two events. |